Dear MyDx Employees, Customers, Shareholders, Partners, Associates, Friends and Fans,
Thank you kindly for your support of our mission to help people Trust & VerifyTM what they put into their minds and bodies.
Please find below recent Press Announcements for MyDx, Inc.:
With your support, CDx, Inc. has successfully raised $7.6 million dollars and has completed a reverse merger with MyDx, Inc., becoming a publicly traded company on the NASDAQ OTC Exchange under ticker symbol MYDX.
MyDx, Inc. has further secured its competitive position and first mover advantage in the handheld chemical analysis space by executing an exclusive sublicense agreement with Next Dimension Technologies for its electronic nose chemical sensing technology used by NASA and funded by the Bill & Melinda Gates Foundation.
Per our plans, MyDx, Inc. has successfully up-listed to the NASDAQ OTCQB marketplace, further marking our commitment to the high level of financial and corporate disclosure that is required to participate on this exchange.
Other Notable Events & Media Mentions:
Presentation Time: Monday June 1, 2015 at 9:30 a.m. PST in Los Angeles | Live Webcast Link
The MyDx Analyzer was mentioned in the Chicago Tribune after it was exhibited at the MMJ Business Conference & Expo.
MyDx, Inc. was featured at several events including the Marijuana Investor Summit and Med MJ conferences in Denver, Colorado, where we participated in panels covering Technology and Software in the MMJ Space. We are also grateful for the opportunity to contribute to the “Shark Tank” Panel sessions at the Arcview Investor Forum in Washington, DC., the same forum where CDx kicked off its Series A financing activities back in January of 2014.
We are excited and look forward to keeping you updated on our products and company. If you prefer real time updates, please sign up here.
In the meantime, kindly let us know if you have any questions and thank you again for your continued support.
Daniel R. Yazbeck
Chairman & CEO